Canaccord Adams Downgrades AEterna Zentaris (AEZS) to Speculative Buy; Negative Phase III Study Results
Tweet Send to a Friend
Canaccord Adams downgrades AEterna Zentaris (Nasdaq: AEZS) from Buy to Speculative Buy. Price target lowered to $1.65 from $3.20.
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
